Product Information
VENLAFAXINE HCL ER 225 MG TAB is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.4614 per EA under NDC 75834021990. Its NADAC has been published 326 times since May 27, 2020.
FDA first approved this application on Aug 29, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
225 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834021990
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211323FDA Approved
8/29/2019
TE Code
AB
On Market Since
9/6/2019
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 225 MG TAB has been published 326 times since May 27, 2020, and over the history we have for it it has declined 94.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4614 per EA |
|---|---|
| All-time high | $9.0921 (Jun 10, 2020) |
| All-time low | $0.4592 (Nov 20, 2024) |
| 52-week high | $0.6770 |
| 52-week low | $0.4614 |
| Median price | $1.2060 |
| Average price | $2.0610 |
| Largest weekly change | +54.1% (Feb 22, 2023) |
| Weeks tracked | 326 |
| Tracking since | May 27, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 225 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 225 MG TAB, manufactured by Nivagen Pharmaceuticals Inc., is $0.4614 per EA (NDC 75834021990), effective Aug 19, 2026.
How has the price of VENLAFAXINE HCL ER 225 MG TAB changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 225 MG TAB has declined 94.9%. It has been tracked across 326 weekly CMS publications since May 27, 2020.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 225 MG TAB?
Since May 27, 2020, the NADAC for VENLAFAXINE HCL ER 225 MG TAB has ranged from a low of $0.4592 (Nov 20, 2024) to a high of $9.0921 (Jun 10, 2020), with a median of $1.2060 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 225 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VENLAFAXINE HCL ER 225 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 225 MG TAB?
VENLAFAXINE HCL ER 225 MG TAB (NDC 75834021990) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.